Hospital readmission following pediatric heart transplantation.
pediatric heart transplantation
readmission
Journal
Pediatric transplantation
ISSN: 1399-3046
Titre abrégé: Pediatr Transplant
Pays: Denmark
ID NLM: 9802574
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
10
05
2019
revised:
26
06
2019
accepted:
01
07
2019
pubmed:
5
9
2019
medline:
26
8
2020
entrez:
5
9
2019
Statut:
ppublish
Résumé
The frequency, indications, and outcomes for readmission following pediatric heart transplantation are poorly characterized. A better understanding of this phenomenon will help guide strategies to address the causes of readmission. Data from the Clinical Trials in Organ Transplantation for Children (CTOTC-04) multi-institutional collaborative study were utilized to determine incidence of, and risk factors for, hospital readmission within 30 days and 1 year from initial hospital discharge. Among 240 transplants at 8 centers, 227 subjects were discharged and had follow-up. 129 subjects (56.8%) were readmitted within one year; 71 had two or more readmissions. The 30-day and 1-year freedom from readmission were 70.5% (CI: 64.1%, 76.0%) and 42.2% (CI: 35.7%, 48.7%), respectively. The most common indications for readmissions were infection followed by rejection and fever without confirmed infection, accounting for 25.0%, 10.6%, and 6.2% of readmissions, respectively. Factors independently associated with increased risk of first readmission within 1 year (Cox proportional hazard model) were as follows: transplant in infancy (P = .05), longer transplant hospitalization (P = .04), lower UNOS urgency status (2/IB vs 1A) at transplant (P = .04), and Hispanic ethnicity (P = .05). Hospital readmission occurs frequently in the first year following discharge after heart transplantation with highest risk in the first 30 days. Infection is more common than rejection as cause for readmission, with death during readmission being rare. A number of patient factors are associated with higher risk of readmission. A fuller understanding of these risk factors may help tailor strategies to reduce unnecessary hospital readmission.
Identifiants
pubmed: 31483086
doi: 10.1111/petr.13561
pmc: PMC8455069
mid: NIHMS1711520
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13561Subventions
Organisme : NIAID NIH HHS
ID : U01 AI077867
Pays : United States
Organisme : NIAID NIH HHS
ID : UM2 AI117870
Pays : United States
Organisme : NIH HHS
ID : U01AI077867
Pays : United States
Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
J Heart Lung Transplant. 2018 Apr;37(4):467-476
pubmed: 28619383
J Thorac Dis. 2014 Aug;6(8):1080-96
pubmed: 25132975
Cancer. 2017 Oct 1;123(19):3781-3790
pubmed: 28542918
Am J Transplant. 2018 Sep;18(9):2163-2174
pubmed: 29442424
Health Aff (Millwood). 2014 Aug;33(8):1337-44
pubmed: 25092834
J Heart Lung Transplant. 2017 Sep;36(9):996-1003
pubmed: 28583371
Med Care Res Rev. 2004 Jun;61(2):225-40
pubmed: 15155053
Am J Transplant. 2004 Mar;4(3):384-9
pubmed: 14961991
Pediatr Transplant. 2017 Feb;21(1):
pubmed: 27891727
Pediatr Transplant. 2018 May;22(3):e13130
pubmed: 29473271
Ann Thorac Surg. 2012 Aug;94(2):564-71; discussion 571-2
pubmed: 22704799
J Heart Lung Transplant. 2005 Nov;24(11):1710-20
pubmed: 16297770
Am J Transplant. 2018 Sep;18(9):2135-2147
pubmed: 29446208